Literature DB >> 22899870

Resistant hypertension and the neglected antihypertensive: sodium restriction.

Rajiv Agarwal.   

Abstract

Resistant hypertension is defined as blood pressure (BP) that remains above goal (such as 140/90 mmHg or more) in spite of the concurrent use of three antihypertensive agents of different classes. Ideally, one of the three agents should be a diuretic and all agents should be prescribed at optimal dose amounts. Prevalent among 15% of the treated hypertensives, the risk factors for resistant hypertension include older age, chronic kidney disease (CKD), obesity and diabetes mellitus. Causes of resistant hypertension can be classified into four groups: poor adherence, biological-behavioral factors, CKD and secondary causes, and drugs or exogenous substances. However, before labeling the diagnosis of resistant hypertension, it is important to exclude pseudo-resistant hypertension using home BP monitoring in most patients and ambulatory BP monitoring in a few. Before thinking about the next antihypertensive drug, it is important to restrict dietary sodium. Educating the patient on how to interpret the food label and providing feedback by assessing sodium intake with 24 h urine collection are effective sodium restriction strategies. Sodium restriction can lower BP and among patients with proteinuria can even enhance the anti-proteinuric effects of drugs that block the renin-angiotensin system. Sodium restriction is therefore a valuable but a neglected antihypertensive.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22899870     DOI: 10.1093/ndt/gfs384

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  A Randomized Crossover Trial of Dietary Sodium Restriction in Stage 3-4 CKD.

Authors:  Rajiv Saran; Robin L Padilla; Brenda W Gillespie; Michael Heung; Scott L Hummel; Vimal Kumar Derebail; Bertram Pitt; Nathan W Levin; Fansan Zhu; Samer R Abbas; Li Liu; Peter Kotanko; Philip Klemmer
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-16       Impact factor: 8.237

2.  Brazilian Position Statement on Resistant Hypertension - 2020.

Authors:  Juan Carlos Yugar-Toledo; Heitor Moreno Júnior; Miguel Gus; Guido Bernardo Aranha Rosito; Luiz César Nazário Scala; Elizabeth Silaid Muxfeldt; Alexandre Alessi; Andrea Araújo Brandão; Osni Moreira Filho; Audes Diógenes de Magalhães Feitosa; Oswaldo Passarelli Júnior; Dilma do Socorro Moraes de Souza; Celso Amodeo; Weimar Kunz Sebba Barroso; Marco Antônio Mota Gomes; Annelise Machado Gomes de Paiva; Eduardo Costa Duarte Barbosa; Roberto Dischinger Miranda; José Fernando Vilela-Martin; Wilson Nadruz Júnior; Cibele Isaac Saad Rodrigues; Luciano Ferreira Drager; Luiz Aparecido Bortolotto; Fernanda Marciano Consolim-Colombo; Márcio Gonçalves de Sousa; Flávio Antonio de Oliveira Borelli; Sérgio Emanuel Kaiser; Gil Fernando Salles; Maria de Fátima de Azevedo; Lucélia Batista Neves Cunha Magalhães; Rui Manoel Dos Santos Póvoa; Marcus Vinícius Bolívar Malachias; Armando da Rocha Nogueira; Paulo César Brandão Veiga Jardim; Thiago de Souza Veiga Jardim
Journal:  Arq Bras Cardiol       Date:  2020 May-Jun       Impact factor: 2.000

Review 3.  Controlled Versus Uncontrolled Resistant Hypertension: Are They in the Same Bag?

Authors:  J C Yugar-Toledo; V Brunelli; J F Vilela-Martin; A Fattori; H Moreno
Journal:  Curr Hypertens Rep       Date:  2018-03-27       Impact factor: 5.369

4.  Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.

Authors:  Keith M Diaz; John N Booth; David A Calhoun; Marguerite R Irvin; George Howard; Monika M Safford; Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2014-06-09       Impact factor: 10.190

5.  A Coaching Program to Improve Dietary Intake of Patients with CKD: ENTICE-CKD.

Authors:  Jaimon T Kelly; Marguerite Conley; Tammy Hoffmann; Jonathan C Craig; Allison Tong; Dianne P Reidlinger; Marina M Reeves; Kirsten Howard; Rathika Krishnasamy; Jagadeesh Kurtkoti; Suetonia C Palmer; David W Johnson; Katrina L Campbell
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-28       Impact factor: 8.237

6.  Factors impacting sodium restriction in patients with chronic kidney disease: a cohort study from a Chinese center.

Authors:  Yu Wang; Fangfang Yu; Yunfei Bao; Luxia Zhang; Hong Wang
Journal:  Int Urol Nephrol       Date:  2016-02-02       Impact factor: 2.370

Review 7.  Emerging concepts for patients with treatment-resistant hypertension.

Authors:  Alfonso Eirin; Stephen C Textor; Lilach O Lerman
Journal:  Trends Cardiovasc Med       Date:  2016-05-17       Impact factor: 6.677

8.  Results of a novel screening tool measuring dietary sodium knowledge in patients with chronic kidney disease.

Authors:  Julie A Wright Nunes; Cheryl A M Anderson; Jane H Greene; Talat Alp Ikizler; Kerri L Cavanaugh
Journal:  BMC Nephrol       Date:  2015-03-31       Impact factor: 2.388

9.  Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.

Authors:  Elizabeth do Espirito Santo Cestário; Letícia Aparecida Barufi Fernandes; Luiz Tadeu Giollo-Júnior; Jéssica Rodrigues Roma Uyemura; Camila Suemi Sato Matarucco; Manoel Idelfonso Paz Landim; Luciana Neves Cosenso-Martin; Lúcia Helena Bonalume Tácito; Heitor Moreno; José Fernando Vilela-Martin; Juan Carlos Yugar-Toledo
Journal:  Trials       Date:  2018-02-12       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.